Reliq Health Technologies, Inc. Announces Five New US Contracts and New Clinical Trial Go-Live
June 09 2022 - 3:01AM
Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or
WKN:A2AJTB) (“
Reliq” or the
“
Company”), a rapidly growing global healthcare
technology company that develops innovative Virtual Care solutions
for the multi-billion dollar Healthcare market, today announced
that it has signed five new contracts with physician practices and
home health agencies that are expected to add over 2,500 patients
in California, Texas, Michigan and Maryland to Reliq’s platform
this year. The Company also announced that its iUGO Care platform
is now being used in a new clinical trial.
“We are very pleased to be going live in another
clinical trial, this one for diabetics using both standard
glucometers and continuous blood glucose monitors,” said Dr. Lisa
Crossley, CEO at Reliq Health Technologies, Inc. “The ability of
the iUGO Care platform to connect to a wide range of connected
devices is a key competitive advantage for Reliq in the virtual
care and clinical trials markets. The diabetes clinical trial will
also be utilising iUGO Voice, Reliq’s interactive voice recognition
technology, to facilitate patient follow up. We are also excited to
announce that we have signed five new contracts with healthcare
providers in California, Texas, Maryland and Michigan. These
clients are expected to add over 2,500 patients to our platform in
2022, at an average revenue of $50 per patient per month at 75%
gross margin.”
Reliq Health
Reliq Health Technologies is a rapidly growing
global healthcare technology company that specializes in developing
innovative Virtual Care solutions for the multi-billion dollar
Healthcare market. Reliq’s powerful iUGO Care platform supports
care coordination and community-based virtual healthcare. iUGO Care
allows complex patients to receive high quality care at home,
improving health outcomes, enhancing quality of life for patients
and families and reducing the cost of care delivery. iUGO Care
provides real-time access to remote patient monitoring data,
allowing for timely interventions by the care team to prevent
costly hospital readmissions and ER visits. Reliq Health
Technologies trades on the TSX Venture under the symbol RHT, on the
OTC as RQHTF and on the WKN as A2AJTB.
ON BEHALF OF THE BOARD“Dr. Lisa Crossley”CEO and Director
For further information please contact:
Company ContactInvestor Relations at
ir@reliqhealth.com
US Investor Relations ContactInvestor
RelationsLytham Partners, LLCBen ShamsianNew York |
Phoenix646-829-9701shamsian@lythampartners.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward
Looking Information
Certain statements in this press release
constitute forward-looking statements, within the meaning of
applicable securities laws. All statements that are not historical
facts, including without limitation, statements regarding future
estimates, plans, programs, forecasts, projections, objectives,
assumptions, expectations or beliefs of future performance, are
"forward-looking statements".
We caution you that such "forward-looking
statements" involve known and unknown risks and uncertainties that
could cause actual and future events to differ materially from
those anticipated in such statements.
Forward-looking statements include, but are not
limited to, statements with respect to commercial operations,
including technology development, anticipated revenues, projected
size of market, and other information that is based on forecasts of
future results, estimates of amounts not yet determinable and
assumptions of management.
Reliq Health Technologies Inc. (the
"Company") does not intend and does not assume any
obligation, to update these forward-looking statements except as
required by law. These forward-looking statements involve risks and
uncertainties relating to, among other things, technology
development and marketing activities, the Company's historical
experience with technology development, uninsured risks. Actual
results may differ materially from those expressed or implied by
such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Reliq Health Technologies (TSXV:RHT)
Historical Stock Chart
From Sep 2023 to Sep 2024